flecainide has been researched along with Allergic Encephalomyelitis in 2 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flecainide was also potent in suppressing microglial activation in experimental autoimmune encephalomyelitis." | 5.39 | Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. ( Bechtold, D; Chauhdry, S; Hassoon, P; Lee, W; Malpass, K; Morsali, D; Palchaudhuri, U; Piers, T; Pocock, J; Roach, A; Smith, KJ; Snell, DM, 2013) |
| "Flecainide was also potent in suppressing microglial activation in experimental autoimmune encephalomyelitis." | 1.39 | Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis. ( Bechtold, D; Chauhdry, S; Hassoon, P; Lee, W; Malpass, K; Morsali, D; Palchaudhuri, U; Piers, T; Pocock, J; Roach, A; Smith, KJ; Snell, DM, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morsali, D | 1 |
| Bechtold, D | 1 |
| Lee, W | 1 |
| Chauhdry, S | 1 |
| Palchaudhuri, U | 1 |
| Hassoon, P | 1 |
| Snell, DM | 1 |
| Malpass, K | 1 |
| Piers, T | 1 |
| Pocock, J | 1 |
| Roach, A | 1 |
| Smith, KJ | 2 |
| Bechtold, DA | 1 |
| Kapoor, R | 1 |
2 other studies available for flecainide and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Safinamide and flecainide protect axons and reduce microglial activation in models of multiple sclerosis.
Topics: Alanine; Animals; Benzylamines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; | 2013 |
Axonal protection using flecainide in experimental autoimmune encephalomyelitis.
Topics: Animals; Axons; Encephalomyelitis, Autoimmune, Experimental; Flecainide; Male; Neuroprotective Agent | 2004 |